
Hans S. Keirstead
individual
About
Hans S. Keirstead is a neuroscientist, stem cell researcher, and biotech entrepreneur best known for his work at UC Irvine and for founding or leading multiple regenerative-medicine companies. He is Chief Executive Officer and board member of AIVITA Biomedical, Chairman of Immunis, and has also held leadership or advisory roles with the Human Immunome Project, Remiges Ventures, and Regeneration Biomedical. His 2014 California Stem Cell exit produced SEC-documented personal equity consideration, while most of his public profile remains that of a scientific and biotech ecosystem operator rather than a professional investor.
Areas of interest
stem cellsregenerative medicinebiotechcancer immunotherapyimmunologylongevityage-related immune declineneurologyspinal cord injuryretinal diseasemotor neuron diseasevaccinesAI in health